← back to search

Xiaolin Lin

University of Oslo · NO
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Biology, Major histocompatibility complex, IRF1, Nasopharyngeal carcinoma, MHC class I, and Glucose homeostasis.
h-index
citations
458
works
5
NIH funding
primary concept
email

Recent publications

Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
Theranostics 2024cited by 77position: middledoi
Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA
Nature Communications 2022cited by 105position: middledoi
Loss of ATF4 leads to functional aging-like attrition of adult hematopoietic stem cells
Science Advances 2021cited by 34position: middledoi
MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axis
Journal of Cancer 2021cited by 31position: middledoi
MiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in Mice
PLoS Genetics 2016cited by 110position: firstdoi
miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells
Biochemical and Biophysical Research Communications 2013cited by 132position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shengchun Wang · Southern Medical University2 papers (2013–2016)Yan Sun · Xi'an Honghui Hospital2 papers (2021–2022)Jun-Shuang Jia · Wenzhou Medical University2 papers (2016–2021)Kai‐Tai Yao · Southern Medical University2 papers (2013–2016)Meijuan Dian · Southern Medical University2 papers (2021–2022)Raoying Xie · The First Affiliated Hospital, Sun Yat-sen University2 papers (2013–2016)Wei-Chao Hao · Wenzhou Medical University2 papers (2021–2022)Zijian Li · Xiamen University2 papers (2021–2022)Kang Xu · Carnegie Mellon University2 papers (2013–2016)Dong Xiao · Second Affiliated Hospital of Guangzhou Medical University2 papers (2016–2021)Wentao Zhao · Xiamen University2 papers (2013–2021)Tao Du · Qingdao University1 papers (2016–2016)Lianxin Liu · Harbin Medical University1 papers (2024–2024)Ying Zhou · Jiangsu University1 papers (2021–2021)Xun Zhu · Sun Yat-sen University1 papers (2021–2021)Ximeng Liu · The University of Texas MD Anderson Cancer Center1 papers (2021–2021)Wei Zhou · University of Houston1 papers (2021–2021)Fei Gao · National Center for Drug Screening1 papers (2013–2013)Yongliang Sun · Southern Medical University1 papers (2013–2013)Ruiyu Liu · Hebei Medical University1 papers (2016–2016)